From a biological point of view, IDH mutations hesitate in increased IDH1/2 activity, causing changes in cell metabolism and subsequent accumulation of tumour metabolite 2-hydroxyglutaric acid (2-HG) [64,65]. Here, IDH1 is linked to neoplasm.